Diabetes Mellitus after SARS-CoV-2 Infection: An Epidemiological Review
Diabetes mellitus (DM) is among the major global public health issues. According to recent projections, a continued rise in DM prevalence is expected in the following decades. The research has shown that DM is associated with poorer outcomes of coronavirus disease 2019 (COVID-19). However, there is...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-05-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/13/6/1233 |
| _version_ | 1797593881105137664 |
|---|---|
| author | Irena Ilic Milena Ilic |
| author_facet | Irena Ilic Milena Ilic |
| author_sort | Irena Ilic |
| collection | DOAJ |
| description | Diabetes mellitus (DM) is among the major global public health issues. According to recent projections, a continued rise in DM prevalence is expected in the following decades. The research has shown that DM is associated with poorer outcomes of coronavirus disease 2019 (COVID-19). However, there is growing evidence suggesting that COVID-19 is associated with new-onset DM type 1 and type 2. This review aims to summarize the current knowledge about the new onset of DM following COVID-19. All identified studies were longitudinal, and they have predominantly shown a significantly increased risk for new-onset DM (both type 1 and type 2) following a SARS-CoV-2 infection. Increased risk of poorer COVID-19 outcomes (mechanical ventilation, death) was noted in persons with new-onset DM following SARS-CoV-2 infection. Studies investigating risk factors for new-onset DM in COVID-19 patients showed that severe disease, age, ethnicity, ventilation, and smoking habits were associated with DM occurrence. The information summarized in this review presents a valuable source of evidence for healthcare policymakers and healthcare workers in the effort of planning prevention measures for new-onset DM after SARS-CoV-2 infection and the timely identification and appropriate treatment of patients with COVID-19 who could be at greater risk for new-onset DM. |
| first_indexed | 2024-03-11T02:14:47Z |
| format | Article |
| id | doaj.art-c30baa23fe7d4381af4db4efcf4d90bb |
| institution | Directory Open Access Journal |
| issn | 2075-1729 |
| language | English |
| last_indexed | 2024-03-11T02:14:47Z |
| publishDate | 2023-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Life |
| spelling | doaj.art-c30baa23fe7d4381af4db4efcf4d90bb2023-11-18T11:16:27ZengMDPI AGLife2075-17292023-05-01136123310.3390/life13061233Diabetes Mellitus after SARS-CoV-2 Infection: An Epidemiological ReviewIrena Ilic0Milena Ilic1Faculty of Medicine, University of Belgrade, 11000 Belgrade, SerbiaDepartment of Epidemiology, Faculty of Medical Sciences, University of Kragujevac, 34000 Kragujevac, SerbiaDiabetes mellitus (DM) is among the major global public health issues. According to recent projections, a continued rise in DM prevalence is expected in the following decades. The research has shown that DM is associated with poorer outcomes of coronavirus disease 2019 (COVID-19). However, there is growing evidence suggesting that COVID-19 is associated with new-onset DM type 1 and type 2. This review aims to summarize the current knowledge about the new onset of DM following COVID-19. All identified studies were longitudinal, and they have predominantly shown a significantly increased risk for new-onset DM (both type 1 and type 2) following a SARS-CoV-2 infection. Increased risk of poorer COVID-19 outcomes (mechanical ventilation, death) was noted in persons with new-onset DM following SARS-CoV-2 infection. Studies investigating risk factors for new-onset DM in COVID-19 patients showed that severe disease, age, ethnicity, ventilation, and smoking habits were associated with DM occurrence. The information summarized in this review presents a valuable source of evidence for healthcare policymakers and healthcare workers in the effort of planning prevention measures for new-onset DM after SARS-CoV-2 infection and the timely identification and appropriate treatment of patients with COVID-19 who could be at greater risk for new-onset DM.https://www.mdpi.com/2075-1729/13/6/1233SARS-CoV-2diabetes mellitusepidemiologyrisk factors |
| spellingShingle | Irena Ilic Milena Ilic Diabetes Mellitus after SARS-CoV-2 Infection: An Epidemiological Review Life SARS-CoV-2 diabetes mellitus epidemiology risk factors |
| title | Diabetes Mellitus after SARS-CoV-2 Infection: An Epidemiological Review |
| title_full | Diabetes Mellitus after SARS-CoV-2 Infection: An Epidemiological Review |
| title_fullStr | Diabetes Mellitus after SARS-CoV-2 Infection: An Epidemiological Review |
| title_full_unstemmed | Diabetes Mellitus after SARS-CoV-2 Infection: An Epidemiological Review |
| title_short | Diabetes Mellitus after SARS-CoV-2 Infection: An Epidemiological Review |
| title_sort | diabetes mellitus after sars cov 2 infection an epidemiological review |
| topic | SARS-CoV-2 diabetes mellitus epidemiology risk factors |
| url | https://www.mdpi.com/2075-1729/13/6/1233 |
| work_keys_str_mv | AT irenailic diabetesmellitusaftersarscov2infectionanepidemiologicalreview AT milenailic diabetesmellitusaftersarscov2infectionanepidemiologicalreview |